Delivery Order SPE2DB20D3103-SPE2DB23FN6W0
- Not listed
- The federal contract award, identified as SPE2DX15D2209|SPE2DX25FBKPL, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $2,373.00, is for the delivery of SEVOFLURANE INHALATION LIQUID 250ML, a medical supply. This is a Firm Fixed Price, Delivery Order contract with a completion date of January 8, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- This federal contract award, with ID SPE2DB24D6044|SPE2DB25FLHUZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sevoflurane Inhalation Liquid 250ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,994.70 and a performance period through April 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is...
- This federal contract award, with ID SPE2DB22D3016|SPE2DB25FALV6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sevoflurane Inhalation Liquid 250ML, a critical medical commodity, to support military healthcare programs globally. The contract has a ceiling value of $1,630.00 and is a Delivery Order under an Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of SEVOFLURANE INHALATION LIQUID 250ML to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a ceiling value of $2,320.55 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2024. This contract award is not associated with a set-aside designation....
- This federal contract award is for the delivery of SEVOFLURANE INHALATION LIQUID 250ML to the Defense Logistics Agency (DLA), a defense agency. The $16,530.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 12, 2025, with a completion date of May 13, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,414.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SEVOFLURANE INHALATION LIQUID 250ML, with a performance period through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $5,467.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SEVOFLURANE INHALATION LIQUID 250ML, a medical product used in healthcare settings. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,733.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of 4558100828 - Sevoflurane Inhalation Liquid 250ML, a...
- This federal contract award, valued at $5,939.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Sevoflurane Inhalation Liquid 250ml, a commonly used anesthetic medication. This is a Firm Fixed Price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen, through its Corporate Office division, is a significant supplier of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $4,556.10, is for the delivery of Sevoflurane Inhalation Liquid 250ML, a critical pharmaceutical product. This was a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN6W0Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN6W0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4561220327 - SEVOFLURANE INHALATION LIQUID 250ML, a pharmaceutical product, and has a ceiling value of $3,644.96. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 13, 2023. Amerisourcebergen Drug Corp is a for-profit pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. This contract award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/12/23 |